Skip Navigation

European Heart Journal 1999 20(22):1609-1611; doi:10.1053/euhj.1999.1704
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Murdoch, D.R.
Right arrow Articles by McMurray, J.J.V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murdoch, D.R.
Right arrow Articles by McMurray, J.J.V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Cardiac cachexia—lean and mean

D.R. Murdoch and J.J.V. McMurray

West Glasgow Hospitals University NHS Trust, Glasgow, Scotland, U.K.

References

  1. Katz AM, Katz PB. Diseases of heart in works of Hippocrates. Br Heart J. 1962;24:257–264[Abstract/Free Full Text]
  2. Zhao SP, Zeng LH. Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia. Int J Cardiol. 1997;58:257–261[CrossRef][ISI][Medline]
  3. Ansari A. Syndromes of cardiac cachexia and the cachectic heart: current perspective. Prog Cardiovasc Dis. 1987;30:45–60[CrossRef][ISI][Medline]
  4. Morrison WL, Edwards RH. Cardiac cachexia. BMJ. 1991;302:301–302[ISI][Medline]
  5. Riley M, Elborn JS, McKane WR, Bell N, Stanford CF, Nicholls DP. Resting energy expenditure in chronic cardiac failure. Clin Sci. 1991;80:633–639[Medline]
  6. Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Int Med. 1994;121:860–862[Abstract/Free Full Text]
  7. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J. 1991;66:356–358[Abstract/Free Full Text]
  8. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236–241[Abstract]
  9. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor-necrosis-factor and inducible nitric-oxide synthase in dilated cardiomyopathy. Lancet. 1996;347:1151–1155[CrossRef][ISI][Medline]
  10. Anker SD, Ponikowski P, Varney S. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–1053[CrossRef][ISI][Medline]
  11. Anker SD, Swan JW, Volterrani M. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J. 1997;18:259–269[Abstract/Free Full Text]
  12. Anker SD, Clark AL, Teixeira MM, Hellewell PG, Coat AJS. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol. 1999;83:612–615[CrossRef][ISI][Medline]
  13. Anker SD, Chua TP, Ponikowski P. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96:526–534[Abstract/Free Full Text]
  14. Swan JW, Anker SD, Walton C. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 1997;30:527–532[Abstract]
  15. Ponikowski P, Piepoli M, Chua TP. The impact of cachexia on cardiorespiratory reflex control in chronic heart failure. Eur Heart J. 1999;20:1667–1675[Abstract/Free Full Text]
  16. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with cardiac disease. N Engl J Med. 1971;285:877–883[ISI][Medline]
  17. Farrell TG, Odemuyiwa O, Bashir Y. Prognostic value of baroreflex sensitivity testing after acute myocardial-infarction. Br Heart J. 1992;67:129–137[Abstract/Free Full Text]
  18. Vadell C, Segui MA, GimenezArnau JM. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. American Journal Of Clinical Oncology-Cancer Clinical Trials. 1998;21:347–351
  19. Barber MD, Ross JA, Fearon KCH. An eicosapentaenoic acid-enriched nutritional supplement reverses cachexia in patients with advanced pancreatic cancer. Br J Surg. 1998;85:46[CrossRef][Medline]
  20. Wigmore SJ, Fearon KCH, Maingay JP, Ross JA. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci. 1997;92:215–221[Medline]
  21. Gagnon B, Bruera E. A review of the drug treatment of cachexia associated with cancer. Drugs. 1998;55:675–688[CrossRef][ISI][Medline]
  22. Abraham E, Anzueto A, Gutierrez G. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet. 1998;351:929–933[ISI][Medline]
  23. Stack WA, Mann SD, Roy AJ. Randomised controlled trial of cdp571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet. 1997;349:521–524[CrossRef][ISI][Medline]
  24. Elliott MJ, Maini RN, Feldmann M. Randomized double-blind comparison of chimeric monoclonal-antibody to tumor-necrosis-factor-alpha (Ca2) versus placebo in rheumatoid-arthritis. Lancet. 1994;344:1105–1110[CrossRef][ISI][Medline]
  25. Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet. 1998;351:1091–1093[CrossRef][ISI][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Exp PhysiolHome page
D. F. Goldspink, J. G. Burniston, G. M. Ellison, W. A. Clark, and L.-B. Tan
Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways?
Exp Physiol, July 1, 2004; 89(4): 407 - 416.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Murdoch, D.R.
Right arrow Articles by McMurray, J.J.V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murdoch, D.R.
Right arrow Articles by McMurray, J.J.V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?